Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Zimberelimab (Synonyms: WBP-3055, WBP3055, GLS-010, GLS010, AB-122, AB122)

Catalog No. T76709 Copy Product Info
🥰Excellent
Zimberelimab (GLS-010) is a humanized monoclonal antibody targeting PD-1, with antitumor activity. It blocks the interaction between PD-L1, PD-L2, and PD-1 on the cell surface, and is used in studies of cervical cancer and non-small cell lung cancer.

Zimberelimab

Copy Product Info
🥰Excellent
Catalog No. T76709
Synonyms WBP-3055, WBP3055, GLS-010, GLS010, AB-122, AB122

Zimberelimab (GLS-010) is a humanized monoclonal antibody targeting PD-1, with antitumor activity. It blocks the interaction between PD-L1, PD-L2, and PD-1 on the cell surface, and is used in studies of cervical cancer and non-small cell lung cancer.

Zimberelimab
Cas No. 2259860-24-5
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$247In StockIn Stock
5 mg$645In StockIn Stock
10 mg$987-In Stock
25 mg$1,530-In Stock
50 mg$1,980-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.11% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Zimberelimab (GLS-010) is a humanized monoclonal antibody targeting PD-1, with antitumor activity. It blocks the interaction between PD-L1, PD-L2, and PD-1 on the cell surface, and is used in studies of cervical cancer and non-small cell lung cancer.
Targets&IC50
PD-1 (human):210 pM (EC50)
In vitro
Zimberelimab is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC50 of 210 pM for human PD-1.
Zimberelimab can effectively block the binding of PD-L1 and PD-L2 to PD-1 on the cell surface in CHO-S cells, with IC50 values of 580 pM and 670 pM, respectively. [1]
The equilibrium dissociation constant (KD) between Zimberelimab and PD-1 is 1.75×10-10 M. [2]
In vivo
Zimberelimab showed a statistically significant antitumor effect in the MC38 model of human PD-1 knock-in mice. [2]
SynonymsWBP-3055, WBP3055, GLS-010, GLS010, AB-122, AB122
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetPDCD1/PD-1/CD279
Chemical Properties
Molecular Weight146.54 kDa
Cas No.2259860-24-5
Antibody Information
IsotypeHuman IgG4SP lambda
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Zimberelimab | purchase Zimberelimab | Zimberelimab cost | order Zimberelimab | Zimberelimab in vivo | Zimberelimab in vitro | Zimberelimab molecular weight